Unknown

Dataset Information

0

Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia.


ABSTRACT: Methotrexate (MTX) is a key agent for the treatment of childhood acute lymphoblastic leukemia (ALL). Increased MTX plasma concentrations are associated with a higher risk of adverse drug effects. ATP-binding cassette subfamily C member 2 (ABCC2) is important for excretion of MTX and its toxic metabolite. The ABCC2 -24C>T polymorphism (rs717620) reportedly contributes to variability of MTX kinetics. In the present study, we assessed the association between the ABCC2 -24C>T polymorphism and methotrexate (MTX) toxicities in childhood ALL patients treated with high-dose MTX. A total of 112 Han Chinese ALL patients were treated with high-dose MTX according to the ALL-Berlin-Frankfurt-Muenster 2000 protocol. Our results showed that presence of the -24T allele in ABCC2 gene led to significantly higher MTX plasma concentrations at 48 hours after the start of infusion, which would strengthen over repeated MTX infusion. The -24T allele in ABCC2 gene was significantly associated with higher risks of high-grade hematologic (leucopenia, anemia, and thrombocytopenia) and non-hematologic (gastrointestinal and mucosal damage/oral mucositis) MTX toxicities. This study provides the first evidence that the -24T allele in ABCC2 gene is associated with the severity of MTX toxicities, which add fresh insights into clinical application of high-dose MTX and individualization of MTX treatment.

SUBMITTER: Liu Y 

PROVIDER: S-EPMC3880259 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia.

Liu Yan Y   Yin You Y   Sheng Qi Q   Lu Xiaotong X   Wang Fang F   Lin Zhiyan Z   Tian Huaiping H   Xu Ajing A   Zhang Jian J  

PloS one 20140103 1


Methotrexate (MTX) is a key agent for the treatment of childhood acute lymphoblastic leukemia (ALL). Increased MTX plasma concentrations are associated with a higher risk of adverse drug effects. ATP-binding cassette subfamily C member 2 (ABCC2) is important for excretion of MTX and its toxic metabolite. The ABCC2 -24C>T polymorphism (rs717620) reportedly contributes to variability of MTX kinetics. In the present study, we assessed the association between the ABCC2 -24C>T polymorphism and methot  ...[more]

Similar Datasets

| S-EPMC6761274 | biostudies-literature
| S-EPMC6215054 | biostudies-literature
| S-EPMC7221302 | biostudies-literature
| S-EPMC3948096 | biostudies-literature
| S-EPMC4483916 | biostudies-literature
| S-EPMC8511303 | biostudies-literature
| S-EPMC5514947 | biostudies-literature
| S-EPMC6235695 | biostudies-literature
| S-EPMC4009163 | biostudies-literature
| S-EPMC7839368 | biostudies-literature